1. m6A‐induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma
   Jiamei Wu et al, 2024, Journal of Cellular Physiology CrossRef
2. Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study
   Yihui Ge et al, 2024, Cancer Medicine CrossRef
3. MECOM: a bioinformatics and experimentally identified marker for the diagnosis and prognosis of lung adenocarcinoma
   Anqi Li et al, 2024, Biomarkers in Medicine CrossRef
4. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer
   Miguel A. Ortega et al, 2023, Journal of Personalized Medicine CrossRef
5. Long‑term control in a patient with lung adenocarcinoma, nonbacterial thrombotic endocarditis and multiple systemic emboli: A case report
   Takeshi Kawakami et al, 2024, Experimental and Therapeutic Medicine CrossRef
6. New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy
   Wenhui Tian et al, 2024, The Journal of Gene Medicine CrossRef
7. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques
   Dabao He et al, 2023, Frontiers in Immunology CrossRef